Showing results (391-400 of 644) with videos related to
Sort By:
Pageof 65
Neurobiology of Disease|November 14, 2015
A spectrum of exercise training reduces soluble Aβ in a dose-dependent manner in a mouse model of Alzheimer's diseaseKaitlin M Moore, Renee E Girens, Sara K Larson, et al.Nature|May 25, 2012
Apolipoprotein E controls cerebrovascular integrity via cyclophilin ARobert D Bell, Ethan A Winkler, Itender Singh, et al.The Journal of Clinical Investigation|January 19, 2008
Overexpression of ABCA1 reduces amyloid deposition in the PDAPP mouse model of Alzheimer diseaseSuzanne E Wahrle, Hong Jiang, Maia Parsadanian, et al.Rapid Communications in Mass Spectrometry : RCM|November 23, 2006
Quantitative analysis of amyloid beta peptides in cerebrospinal fluid of Alzheimer's disease patients by immunoaffinity purification and stable isotope dilution liquid chromatography/negative electrospray ionization tandem mass spectrometryTomoyuki Oe, Bradley L Ackermann, Koichi Inoue, et al.Journal of Alzheimer'S Disease : JAD|July 8, 2009
Caffeine suppresses amyloid-beta levels in plasma and brain of Alzheimer's disease transgenic miceChuanhai Cao, John R Cirrito, Xiaoyang Lin, et al.JAMA Neurology|September 15, 2015
Neurogranin as a Cerebrospinal Fluid Biomarker for Synaptic Loss in Symptomatic Alzheimer DiseaseMaartje I Kester, Charlotte E Teunissen, Daniel L Crimmins, et al.Human Molecular Genetics|July 24, 2012
Cerebrospinal fluid APOE levels: an endophenotype for genetic studies for Alzheimer's diseaseCarlos Cruchaga, John S K Kauwe, Petra Nowotny, et al.Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 5, 2018
Cerebrospinal fluid biomarkers measured by Elecsys assays compared to amyloid imagingSuzanne E Schindler, Julia D Gray, Brian A Gordon, et al.The Journal of Biological Chemistry|May 13, 2005
The low density lipoprotein receptor regulates the level of central nervous system human and murine apolipoprotein E but does not modify amyloid plaque pathology in PDAPP miceJohn D Fryer, Ronald B Demattos, Lynn M McCormick, et al.JAMA Neurology|January 8, 2019
Assessment of Racial Disparities in Biomarkers for Alzheimer DiseaseJohn C Morris, Suzanne E Schindler, Lena M McCue, et al.Pageof 65